Literature DB >> 29038121

Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.

Xiaoting Wang1, Kit Wong2, Wenjun Ouyang3, Sascha Rutz4.   

Abstract

Members of the interleukin (IL)-10 family of cytokines play important roles in regulating immune responses during host defense but also in autoimmune disorders, inflammatory diseases, and cancer. Although IL-10 itself primarily acts on leukocytes and has potent immunosuppressive functions, other family members preferentially target nonimmune compartments, such as tissue epithelial cells, where they elicit innate defense mechanisms to control viral, bacterial, and fungal infections, protect tissue integrity, and promote tissue repair and regeneration. As cytokines are prime drug targets, IL-10 family cytokines provide great opportunities for the treatment of autoimmune diseases, tissue damage, and cancer. Yet no therapy in this space has been approved to date. Here, we summarize the diverse biology of the IL-10 family as it relates to human disease and review past and current strategies and challenges to target IL-10 family cytokines for clinical use.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29038121      PMCID: PMC6360861          DOI: 10.1101/cshperspect.a028548

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  261 in total

Review 1.  Mechanisms of interleukin-22's beneficial effects in acute pancreatitis.

Authors:  Chongmin Huan; Daniel Kim; Peiqi Ou; Antonio Alfonso; Albert Stanek
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

3.  Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.

Authors:  J F Colombel; P Rutgeerts; H Malchow; M Jacyna; O H Nielsen; J Rask-Madsen; S Van Deventer; A Ferguson; P Desreumaux; A Forbes; K Geboes; L Melani; M Cohard
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 4.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

5.  Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.

Authors:  S Sturlan; G Oberhuber; B G Beinhauer; B Tichy; S Kappel; J Wang; M A Rogy
Journal:  Carcinogenesis       Date:  2001-04       Impact factor: 4.944

6.  IL-10 controls ultraviolet-induced carcinogenesis in mice.

Authors:  Karin Loser; Jenny Apelt; Maik Voskort; Mariette Mohaupt; Sandra Balkow; Thomas Schwarz; Stephan Grabbe; Stefan Beissert
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 8.  Therapeutic opportunities of the IL-22-IL-22R1 system.

Authors:  Robert Sabat; Wenjun Ouyang; Kerstin Wolk
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

9.  Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.

Authors:  Eveline Trachsel; Frank Bootz; Michela Silacci; Manuela Kaspar; Hartwig Kosmehl; Dario Neri
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Integrative biology approach identifies cytokine targeting strategies for psoriasis.

Authors:  Gayathri K Perera; Chrysanthi Ainali; Ekaterina Semenova; Christian Hundhausen; Guillermo Barinaga; Deepika Kassen; Andrew E Williams; Muddassar M Mirza; Mercedesz Balazs; Xiaoting Wang; Robert Sanchez Rodriguez; Andrej Alendar; Jonathan Barker; Sophia Tsoka; Wenjun Ouyang; Frank O Nestle
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

View more
  44 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 2.  Host-microbiota interactions in inflammatory bowel disease.

Authors:  Roberta Caruso; Bernard C Lo; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

3.  A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.

Authors:  Nikki K Lytle; L Paige Ferguson; Nirakar Rajbhandari; Kathryn Gilroy; Raymond G Fox; Anagha Deshpande; Christian M Schürch; Michael Hamilton; Neil Robertson; Wei Lin; Pawan Noel; Martin Wartenberg; Inti Zlobec; Micha Eichmann; José A Galván; Eva Karamitopoulou; Tami Gilderman; Lourdes Adriana Esparza; Yutaka Shima; Philipp Spahn; Randall French; Nathan E Lewis; Kathleen M Fisch; Roman Sasik; Sara Brin Rosenthal; Marcie Kritzik; Daniel Von Hoff; Haiyong Han; Trey Ideker; Aniruddha J Deshpande; Andrew M Lowy; Peter D Adams; Tannishtha Reya
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

4.  Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer.

Authors:  Lukas W Pfannenstiel; C Marcela Diaz-Montero; Ye F Tian; Joseph Scharpf; Jennifer S Ko; Brian R Gastman
Journal:  Cancer Immunol Res       Date:  2019-02-06       Impact factor: 11.151

5.  Protective Effects of Carbon Dots Derived from Armeniacae Semen Amarum Carbonisata Against Acute Lung Injury Induced by Lipopolysaccharides in Rats.

Authors:  Yusheng Zhao; Yue Zhang; Hui Kong; Guoliang Cheng; Huihua Qu; Yan Zhao
Journal:  Int J Nanomedicine       Date:  2022-01-04

6.  Green synthesized gold nanoparticles from Pseudobulbus Cremastrae seu Pleiones show efficacy against hepatic carcinoma potentially through immunoregulation.

Authors:  Junmo Zhu; Zijing Liu; Youwei Pu; Jie Xu; Sitong Zhang; Yixi Bao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 7.  Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2021-04-09       Impact factor: 3.199

Review 8.  Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task.

Authors:  Guoying Ni; Lu Zhang; Xiaodan Yang; Hejie Li; Bowei Ma; Shelley Walton; Xiaolian Wu; Jianwei Yuan; Tianfang Wang; Xiaosong Liu
Journal:  Hum Vaccin Immunother       Date:  2020-03-11       Impact factor: 3.452

9.  Characterization of Cytokines and Proliferation Marker Ki67 in Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study.

Authors:  Rudolfs Janis Viksne; Gunta Sumeraga; Mara Pilmane
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

10.  The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory than Those in Healthy Controls.

Authors:  Longxian Lv; Huiyong Jiang; Ren Yan; Danyi Xu; Kaicen Wang; Qiangqiang Wang; Xiaoxiao Chen; Lanjuan Li
Journal:  mSystems       Date:  2021-06-22       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.